Evidence map›Paper›PMID 25275130›Full record

ArticleJournal of virology2014

HIV-1 envelope glycan moieties modulate HIV-1 transmission.

Ruizhong Shen, Milan Raska, Diane Bimczok, Jan Novak, Phillip D Smith

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Mechanistic understanding ofThe Journal of biological chemistry · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ruizhong ShenDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA rshen@uab.edu pdsmith@uab.edu.
Milan RaskaDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Immunology, Palacky University in Olomouc, Olomouc, Czech Republic.
Diane BimczokDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jan NovakDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Phillip D SmithDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA VA Medical Center, Birmingham, Alabama, USA rshen@uab.edu pdsmith@uab.edu.
University of Alabama at Birmingham · USBirmingham VA Medical Center · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Mucosal HIV and Immunobiology CenterR24DK064400 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SMITH, PHILLIP D · 2003 to 2012
$4.8M
Immunologic Uniqueness of the Female Genital Tract in HIV PathogenesisP01AI083027 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MESTECKY, JIRI F · 2009 to 2010
$4.0M
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT: PHYSIOLOGYC06RR020136 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARCHASE, RICHARD BANFIELD · 2004 to 2004
$3.6M
Vaginal Dendritic Cells Selectively Transmit HIV-1 Founder VirusR21AI106395 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHEN, RUIZHONG · 2013 to 2014
$391k
Immunobiology of Mucosal Secretions in Highly HIV-Exposed Uninfected WomenR56AI093151 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHEN, RUIZHONG · 2011 to 2011
$366k
NCI NIH HHS NIH P30 CA013148NCI NIH HHS P30 CA013148NCRR NIH HHS C06 RR020136NCRR NIH HHS RR-20136NIAID NIH HHS AI083027NIAID NIH HHS AI093151NIAID NIH HHS AI106395NIAID NIH HHS P01 AI083027NIAID NIH HHS P30 AI027767NIAID NIH HHS R21 AI106395NIAID NIH HHS R56 AI093151NIDDK NIH HHS DK064400NIDDK NIH HHS R24 DK064400
6 · The paper itself

Abstract

unlabelledThe HIV-1 envelope protein (Env) is heavily glycosylated, with approximately 50% of the Env molecular mass being contributed by N-glycans. HIV-1 Env N-glycans shield the protein backbone and have been shown to play key roles in determining Env structure, surface exposure, and, consequently, antigenicity, infectivity, antibody neutralization, and carbohydrate and receptor binding. Studies of HIV-1 glycosylation have focused mainly on the position of glycosylation, rather than the types of glycans. Also, the role of Env glycan moieties on HIV-1 transmission has not been systematically defined. Using viruses with modified Env glycan content and heterogeneity, we examined the effects of Env glycan moieties on the major events of HIV-1 transmission. Compared to viruses with less oligomannose and more complex Env glycans, viruses with more oligomannose and less complex glycans more efficiently (i) transcytosed across an epithelial cell monolayer, (ii) attached to monocyte-derived macrophages (MDMs), (iii) bound monocyte-derived dendritic cells (MoDCs), and (iv) trans-infected primary lymphocytes via MoDCs. However, viruses with more oligomannose and less complex glycans displayed impaired infectivity in TZMbl cells, MDMs, primary lymphocytes, and fresh human intestinal tissue. Thus, N-linked Env glycans display discordant effects on the major events of HIV-1 transmission, with mature oligosaccharide structures on Env playing a crucial role in HIV-1 infection. Env glycosylation should be taken into consideration in the development of vaccine strategies to interdict HIV-1 transmission. IMPORTANCE: HIV-1 Env N-glycans shield the protein backbone and play key roles in determining Env structure and surface exposure, thereby impacting Env antigenicity, infectivity, antibody neutralization, and carbohydrate and receptor binding. Studies of HIV-1 glycosylation have focused mainly on the position of glycosylation, rather than the types of glycans. In the study described in this report, we investigated systematically the role of Env glycan moieties on HIV-1 transmission. We show that N-linked Env glycans display discordant effects on the major events of HIV-1 transmission. These data indicate that Env glycan moieties impact HIV-1 transmission and that modulation of Env glycan moieties offers a potential strategy for the development of therapeutic or prophylactic vaccines against HIV-1.

Indexed as

Virus AttachmentCells, CulturedDendritic Cellsenv Gene Products, Human Immunodeficiency VirusEpithelial CellsHIV-1HumansLymphocytesMacrophagesPolysaccharidesenv Gene Products, Human Immunodeficiency VirusPolysaccharides

Identifiers

PMID25275130
PMCPMC4249159
OpenAlexW2002969307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.